普洛药业：公司产品注射用丁二磺酸腺苷蛋氨酸拟中选第十一批全国药品集中采购

Core Viewpoint - Pro Pharmaceutical (000739) announced that its subsidiary Zhejiang Pro Kangyu Pharmaceutical Co., Ltd. participated in the 11th batch of national centralized drug procurement, with its product, injection adenosine methionine bisulfate, expected to be selected [1] Group 1: Product and Market Impact - The selected product is indicated for conditions such as pre-cirrhosis and intrahepatic cholestasis due to cirrhosis, as well as intrahepatic cholestasis during pregnancy [1] - If the company signs the procurement contract and implements it, it will help expand the sales scale of the related product and increase market share [1] - The potential selection of the product is expected to have a positive impact on the company's future operating performance [1] Group 2: Uncertainty and Future Steps - The procurement contract for the selected product has not yet been signed, indicating uncertainty in subsequent matters [1]